Head and neck cancers (HNSCCs) are notable as a poignant public health menace and rank as the 8th most common cancer type according to a 2020 global estimation. Oral squamous cell carcinoma (OSCC) accounts for 90–95% of oral malignancies in most countries. Moreover, oral cancer as well as Kaposi’s sarcoma-associated herpes virus (KSHV) prevalence demonstrates geographic and population specificity. Immunosuppression in oral cancer patients could trigger the multiplication and transmission of oncogenic γ-herpes viruses in oral cancer patients. The objective of this study was to find out the HHV-8 status in oral squamous cell carcinoma tissues in a group of Sri Lankan male patients. Incisional biopsies of cases and excisional biopsies of controls collected, transported, stored, and dispatched as frozen tissues at -800 C. Then, DNA extracted from frozen specimens using Gentra Puregene Tissue kit (Qiagen, Germany), solid tissue protocol according to the manufacturer’s instructions. Subsequently, real-time PCR was performed to detect HHV 8 in these OSCC cases and FEP controls. HHV- 8 was not detected in 22 OSCC cases and 29 FEP control samples. Thus, HHV-8 viral infections may not be a problem in oral cancer patients in Sri Lanka.